Therefore, these data constitute a promising proof of concept for the usefulness of small molecule anionophores capable of facilitating chloride and bicarbonate transport, in order to develop future CF drugs independent of the CFTR function and thus of the genotype of the CF patient. This evidence concerns the gene CFTR and cystic fibrosis.